| Page | |||||
|---|---|---|---|---|---|
| Trustees and |
advisors | ||||
| Trustees' report |
2-11 | ||||
| Independent | Auditor's | report | |||
| Consolidated | statement | of financial | activities | 16 | |
| Balance sheet | 17 | ||||
| Consolidated | statement | of cash flows | 18 | ||
| Notes to the financial | statements |
| N v 0 I |
N N 0 N |
W | LA Ch h M ID 00 |
COo IDo GO |
CI QI |
GO At |
Ifl GO h |
(h GO lfl |
Pl Pl CO |
0o GO |
lfl M lfl |
o 00 ho |
Ct 0 |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | CO | Pl | h | h | QI | |||||||||||||||
| 14 Ct V I ~V N4i IC' |
0 '00 V |
W | (h IA Ch |
LA Pl QI |
I | 0 QI QI QI |
CI Ql QI QI |
IA ID Pl lfl |
o Pl CO |
IA0 IA Ch |
IU 0 J3 fg 10 ID ftl Vl |
Gt0 T3 Cl fll0 UN |
||||||||
| gl | 10 | |||||||||||||||||||
| '0 Cl V I4t |
gl '0 |
W | ID Yl IA N |
PI COo IDo |
GO GQ |
(II0 LA M |
LA 00 ID |
lfl Qf 0 |
Yl CI CO hPl |
QI Ch ID M Ql |
lflo ID Ql |
o Pl Yl |
0 C fg |
N L |
||||||
| ID | CO | GO | GQ | |||||||||||||||||
| 0o0 (0 |
Ci Ia |
IA | M | Pl | h | f IU 0 N |
8C | |||||||||||||
| Ci Ct0. &C Ci 13 C(0 |
N Vv 0 I |
M (4 0 N |
W | ID ID CO YI 00 |
QI Ch lflo |
QI QI (h |
QI LA 00 Olo |
(0 IA 'ID LA m |
Pi LA CO lfi |
ID Ifl IA CQ m Ch |
QIo CQ ho h |
PI o CI (h |
gtN 0 I-0 NC fg Ol 10 CI VI |
Gt E(0 0K N C Ct E (DJJ |
||||||
| Ci E00C |
10 ~v |
N D C |
tll | h (h GQ IA |
Pl At Ch p OQ IA |
I | CI | ID CI |
h CO m ID |
LA CI U1 Ch fft |
CO Yl CO Ift |
Ol0 U Ec ID |
fg fg UC fgC |
|||||||
| Ci (0 |
Cl | 00 | (C ID |
|||||||||||||||||
| 0 N 8 CO C 13 |
ID '00 |
tll | QI GQ CO Ch |
d(Jl Ch lflo PI |
ID m fft m |
GO IA ID IA Pl |
QI ID (h M |
CI IA IA Qf f |
ID nt LA M tg |
CI M Yl |
CI Mo QI IA CO |
gfI- Ct gfI- Ct |
V-0 fg CL IgI- Cg |
|||||||
| 0C | N Gt |
Cl C |
||||||||||||||||||
| GO Oi 0 (O |
Ci ~V0Z |
GQ | GO h |
I Ci Cl |
Ufg OlC L |
I-0 lf- |
||||||||||||||
| (00C (QC V-0 C Oi E Ct Vi Ci Oi 0 ID 00 |
CI 0 fg Pl 13 GI'0 C GI gl CI CI 0 LL |
E0 I Ct E0VC |
NC0 tgC00 13 fg N C lg U |
N Ct U Ig ChL 'Cl fg I f Cl 0 |
I-fL OI E N IU C |
0 E0 0 lg 0I- |
C0 Ct 0 y 0 0. III |
N 0 C 0 OI .N fg |
fh CI U fg (0 Zl Ig fg C |
Cl I 'Dc 4i CL 4( N 0I- |
0 I0 N'0 C a 0 Ci E 0 E VJSZ |
N C 0 C 0 lg V0 0 Ct IL |
p lg 0 V- OI 0 D N Dl C LL |
'0 lg 0 V'0S I I lgV N8V0 lg lg Cl'0 C II |
C0 U E0I- V- 13 ID I- ID 13 C IU IDD (D fg N N Gl |
C0 Vl IU 0C CII C C fg CL E0UU gf |
N C (U E N fg UC tgC |
| Group | Group | Charity | |||||
|---|---|---|---|---|---|---|---|
| Notes | 2023 | 2022 | 2023 | 2022 | |||
| 6 | f | ||||||
| Fixed assets | |||||||
| Intangible | assets | 13 | 164,651 | 257,542 | 139,330 | 230,066 | |
| Tangible assets | 14 | 146,284 | 184,622 | 146,284 | 184,622 | ||
| Investments | 15 | 3 | 3 | ||||
| 310,935 | 442,164 | 285,617 | 414,691 | ||||
| Current assets | |||||||
| Debtors | 16 | 2,485,802 | 1,315,836 | 2,125,556 | 3,391,175 | ||
| Short term | deposits | 10,618,710 | 8,604,156 | 10,618,710 | 8,604,156 | ||
| Cash at bank and | in hand | 4,166,084 | 4,004,427 | 1,300,546 | 943,951 | ||
| 17,270,596 | 13,924,419 | 14,044,812 | 12,939,282 | ||||
| Creditors: | amounts | ||||||
| falling due | within | one year | 17 | (8,574,119) | (6,958,774) | (5,323,017) | (5,450,997) |
| Net current assets | 8,696,477 | 6,965,645 | 8,721,795 | 7,488,285 | |||
| Total net assets | 9,007,412 | 7,407,809 | 9,007,412 | 7,902,976 | |||
| Funds | 19 | ||||||
| Restricted | funds | 458,382 | 294,505 | 458,382 | 294,505 | ||
| Unrestricted | funds | 8,549,030 | 7,113,304 | 8,549,030 | 7,608,471 | ||
| Funds | 9,007,412 | 7,407,809 | 9,007,412 | 7,902,976 |
| Notes | 2023f | 2022f | ||||
|---|---|---|---|---|---|---|
| Cash flows from operating activities: |
||||||
| Net cash provided | by operating | activities | 24 | 2,017,611 | 1,010,510 | |
| Cash flows from investing activities: |
||||||
| Interest income |
194,299 | 2,940 | ||||
| Purchase of tangible |
and intangible | fixed assets | (35,700) | (224,562) | ||
| Net cash (used in) | investing activities |
(158,599) | (221,622) | |||
| Change in cash and |
cash equivalents | in the | year | 2,176,211 | 788,888 | |
| Cash and cash equivalents at the beginning |
ofthe year | 25 | 12,608,583 | 11,819,695 | ||
| Total cash and cash equivalents | at the | end ofthe | ||||
| year | 25 | 14,784,794 | 12,608,583 |
| Unrestricted | Restricted | Restricted | Total | Unrestricted | Restricted | Total | |
|---|---|---|---|---|---|---|---|
| fundsf | funds f |
2023f | fundsf | funds 6 |
2022 E |
||
| Gifts | 5,433,598 | 1,581,977 | 7,015,575 | 5,424,724 | 941,259 | 6,365,983 | |
| Legacies | 1,111,000 | 1,111,000 | |||||
| Donated | |||||||
| services | 605,291 | 605,291 | 497,812 | 497,812 | |||
| Total | 7,149,889 | 1,581,977 | 8,731,866 | 5,922,536 | 941,259 | 6,863,795 | |
| 3 Income | earned from trading | activities | |||||
| Unrestricted | Restricted | Total | Unrestricted | Restricted | Total | ||
| funds | funds | 2023 | funds | funds | 2022 | ||
| f | f | f | f | f | |||
| Corporate | |||||||
| sponsorship | |||||||
| and | |||||||
| promotions | 199,793 | 199,793 | 148,533 | 148,533 | |||
| Events | 1,855,201 | 1,855I201 | 1,657,549 | 1,657,549 | |||
| Total | 2,054,994 | 2,054,994 | 1,806,082 | 1,806,082 |
| 2023f | 2022 E |
|||||||
|---|---|---|---|---|---|---|---|---|
| Core grants: | ||||||||
| - Maternal | and Fetal Research Unit, St Mary's |
Hospital, | Manchester | 500,000 | 458,000 | |||
| - Tommy's | National Centre for Miscarriage Research |
500,000 | 500,000 | |||||
| - Tommy's | National Centre for Maternity |
Improvement | 500,000 | 500,000 | ||||
| —Tommy's | National Centre for Preterm |
Birth Research | 421,000 | |||||
| - Bio bank, | Royal Infirmary, Edinburgh |
20,000 | ||||||
| - Bio bank, | StThomas' Hospital, London |
20,000 | ||||||
| - Previous | years grants (not fully taken | up)/exceeded | 16,914 | (567,574) | ||||
| 1,937,914 | 930,426 | |||||||
| Non-core | grants: | |||||||
| - Fetal monitoring vest research, St Mary's |
Hospital, | Manchester | 18,908 | |||||
| —PARROT | study, StThomas' Hospital, London |
30,722 | 122,640 | |||||
| —Ursodeoxycholic acid research, St Thomas' |
Hospital, | London | 100,000 | |||||
| - Diabetes | Fellowship Clinic, StThomas' |
Hospital, London |
59,272 | |||||
| - DCMS Tampon Tax Fund Miscarriage Tool, Centre for Maternity Improvement |
Tommy's | National | 324,026 | 59,606 | ||||
| Other research costs | 23,625 | 7,236 | ||||||
| 2,335,195 | 1,279,180 | |||||||
| Outstanding | grants at 1st April 2022 | 2I817,064 | 3,333,360 | |||||
| Grants awarded during the year |
1,937,914 | 930,426 | ||||||
| Paid during | the year | (1,994,998) | (1,446,722) | |||||
| Outstanding | grants at 31 March 2023 falling | due within | one year | 2,759,980 | 2,817,064 |
| 6 Expenditure on education, information, |
and policy | 2023f | 2022f |
|---|---|---|---|
| Pregnancy accreditation General health information provision |
273,814 426,168 |
131,638 290,033 |
|
| Midwife pregnancy helpline Public relations, cause awareness and campaigns |
77,622 596,544 |
104,808 855,332 |
|
| Policy Website and tech development |
292,235 481,123 |
150,614 409,125 |
|
| Supporter e-newsletter and channels Advertising and media |
239,592 739,696 |
118,001 600,686 |
|
| 3,126,794 | 2,660,237 |
| Analysis | ofexpendit | ure | ||||
|---|---|---|---|---|---|---|
| Allocated | ||||||
| support a | ||||||
| Staff costsf | Direct costsf |
governance costsf |
Total 2023f |
|||
| Cost of raising funds Donations and legacies |
673,185 | 698,114 | 260,416 | 1,631,715 | ||
| Corporate and events |
sponsorship, | promotions | 601,211 | 1,101,025 | 231,863 | 1,934,099 |
| 1,274,396 | 1,799,139 | 492,279 | 3,565,814 | |||
| Charitable expenditure Medical research |
336,926 | 2,262,368 | 89,655 | 2,688,949 | ||
| Education, | information | and policy | 1,225,391 | 1,422,361 | 479,041 | 3,126,793 |
| 1,562,317 | 3,684,729 | 568,696 | 5,815,742 | |||
| Total | 2,836,713 | 5,483,868 | 1,060,975 | 9,381,556 |
| nalysis o | fexpenditure | —previous |
year | |||
|---|---|---|---|---|---|---|
| Allocated | ||||||
| support a | ||||||
| Staff costsf | Direct costsf |
governance costs f. |
Total 2022 |
|||
| Cost of raising funds Donations and legacies |
526,113 | 1,144,234 | 266I933 | 1937 280 | ||
| Corporate and events |
sponsorship, | promotions | 480,868 | 1,071,583 | 227,121 | 1,779,572 |
| 1,006,981 | 2,215,817 | 494,054 | 3,716,852 | |||
| Charitable | expenditure | |||||
| Medical research | 139,937 | 1,264,362 | 51,355 | 1,455,654 | ||
| Education, | information | and policy | 1,041,469 | 1,169,520 | 449,248 | 2,660,237 |
| 1,181,406 | 2,433,882 | 500,603 | 4,115,891 | |||
| Total | 2,188,387 | 4,649,699 | 994,657 | 7,832,743 |
| Analysis | of allocated s | upport and gove |
rnance costs |
|||
|---|---|---|---|---|---|---|
| Office | ||||||
| Information technologyf |
Human resources f. |
operating costsf |
Governance costsf |
Total 2023f |
||
| Cost of raising funds Donations and legacies |
61,263 | 23,080 | 167,017 | 9,056 | 260,416 | |
| Corporate promotions |
sponsorship, and events |
54,546 | 20,549 | 148,705 | 8,063 | 231,863 |
| 115,809 | 43,629 | 315,722 | 17,119 | 492,279 | ||
| Charitable expenditure Medical research |
21,091 | 7,946 | 57,500 | 3,118 | 89,655 | |
| Education, | information | |||||
| and policy | 112,695 | 42,455 | 307,233 | 16,658 | 479,041 | |
| 133,786 | 50,401 | 364,733 | 19,776 | 568,696 | ||
| Total | 249,595 | 94,030 | 680,455 | 36,895 | 1,060,975 |
| nalysis o | fallocated sup | port and govern |
ance costs- | previous ye | ar | |
|---|---|---|---|---|---|---|
| Office | ||||||
| Information | Human | operating | Governance | Total | ||
| technology f. |
resources | costs | costs | 2022f | ||
| Cost of raising funds Donations and legacies |
62,234 | 32,211 | 163,538 | 8,950 | 266,933 | |
| Corporate promotions |
sponsorship, and events |
52,952 | 27,407 | 139,147 | 7,615 | 227,121 |
| 115,186 | 59,618 | 302,685 | 16,565 | 494,054 | ||
| Charitable | expenditure | |||||
| Medical research | 11,973 | 6,197 | 31,463 | 1,722 | 51,355 | |
| Education, | information | |||||
| and policy | 104,740 | 54,212 | 275,234 | 15,062 | 449,248 | |
| 116,713 | 60,409 | 306,697 | 16,784 | 500,603 | ||
| Total | 231,899 | 120,027 | 609,382 | 33,349 | 994,657 |
| Net income | Net income | ||
|---|---|---|---|
| Net income is stated after charging: |
2023f | 2022 | |
| Auditor's remuneration |
|||
| - audit fees | 30,950 | 27,440 | |
| - under accrual of prior year's audit fees | 180 | 280 | |
| - non-audit fees |
8,906 | 5,080 | |
| Depreciation and amortisation |
charge | 166,929 | 153,716 |
| Operating lease rentals |
231,515 | 304,692 |
| 0 Group staff costs |
|||
|---|---|---|---|
| 2023 | 2022 | ||
| E | E | ||
| Salaries and wages | 2,363,088 | 1,773,347 | |
| Social security costs | 247,077 | 150,681 | |
| Pension costs | 99,555 | 79,923 | |
| Temporary staff and volunteer |
costs | 126,993 | 184,435 |
| 2,836,713 | 2,188,386 |
| 2023 | 2022 | |||||
|---|---|---|---|---|---|---|
| Number | Number | |||||
| Within | the | range | of | E130,000 to E139,999 | 1 | |
| Within | the | range | of | E120,000 to E129,999 | ||
| Within | the | range | of | E80,000 to E89,999 | ||
| Within | the | range | of | E70,000 to E79,999 | ||
| Within | the | range | of | E60,000 to E69,999 |
| he average | weekly | number of p |
ersons employed during the |
year by department was: |
||
|---|---|---|---|---|---|---|
| 2023 | 2022 | |||||
| Number | Number | |||||
| Charitable | activities | 25 | 16 | |||
| Cost of generating | funds | 26 | 22 | |||
| Management | and administration | ofthe Charity | 9 | 8 | ||
| 60 | 46 |
| 2023f | 2022f | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | Less | than | one | year | 120,352 | 35,668 | |||||
| - | More | than | one | year | and | less | than | five | years | 361,055 | |
| - | More | than | one | year | and | less | than | five | years | 28,027 | |
| 509,434 | 35,668 |
| 13 Intangible |
fixed assets | ||
|---|---|---|---|
| Software and website | Groupf | Charity f |
|
| Cost | |||
| 1 April 2022 | 391,152 | 332,624 | |
| Additions | 15,000 | ||
| Disposals | (2,085) | (2,085) | |
| 31March 2023 | 404,067 | 330,539 | |
| Depreciation | |||
| 1 April 2022 | 133,610 | 102,558 | |
| Charge for the year | 107,891 | 90,736 | |
| Disposals | (2,085) | (2,085) | |
| 31March 2023 | 239,416 | 191,209 | |
| Net book value | |||
| 1 April 2022 | 257,542 | 230,066 | |
| 31 March 2023 | 164,651 | 139,330 |
| 14 Tangible fixed assets |
||
|---|---|---|
| Office equipment | Groupf | Charityf |
| Cost | ||
| 1 April 2022 | 435,412 | 435,412 |
| Additions | 20,700 | 20,700 |
| Disposals | (136,036) | (136,036) |
| 31March 2023 | 320,076 | 320,076 |
| Depreciation | ||
| 1 April 2022 | 250,790 | 250,790 |
| Charge for the year | 59,038 | 59,038 |
| Disposals | (136,036) | (136,036) |
| 31March 2023 | 173,792 | 173,792 |
| Net book value | ||
| 1 April 2022 | 184,622 | 184,622 |
| 31March 2023 | 146,284 | 146,284 |
| Grou | Chari | ||||||
|---|---|---|---|---|---|---|---|
| 2023 f |
2022f | 2023f | 2022f | ||||
| Trade debtors | 341,507 | 126,135 | 251,637 | 2,625 | |||
| Taxation recoverable |
23,775 | 13,803 | 23,775 | 13,803 | |||
| Amounts owed by subsidiary |
companies | 838,422 | 2,434,802 | ||||
| Prepayments | and accrued | income | 2,120,496 | 1,175,898 | 1,011,698 | 939,945 | |
| Other debtors | 24 | 24 | |||||
| 2,485,802 | 1,315,836 | 2,125,556 | 3,391,175 |
| 17 Creditors: |
17 Creditors: |
amounts | amounts | falling due | within one year | within one year | ||
|---|---|---|---|---|---|---|---|---|
| Grou | Chari | |||||||
| 2023f | 2022 f |
2023f | 2022f | |||||
| Trade creditors | 1,193,373 | 875,285 | 562,826 | 1,169,506 | ||||
| VAT payable | 10,195 | 10,876 | 10,196 | 10,876 | ||||
| Medical | grants outstanding | 2,759,980 | 2,817,064 | 2,759,980 | 2,817,064 | |||
| Deferred | income | 4(316,708 | 2,676,360 | 1,099,705 | 887,881 | |||
| Accruals | and other creditors | 293,863 | 579,189 | 890,311 | 565,670 | |||
| 8,574,119 | 6,958,774 | 5,323,018 | 5,450,997 | |||||
| Deferred | income | at 1st | April | 2022 | 2,676,360 | 2,186,803 | 887,881 | 1,022,066 |
| Amount | released | to income | in the year | (2,676,360) | (2,048,594) | (887,881) | (1,022,066) | |
| Income | received | during | the | year | 12,653,890 | 9,162,374 | 9,493,342 | 7,044,087 |
| Amount | released | to income | in the year | (8,337,182) | (6,624,223) | (8,393,637) | (6,156,206) | |
| Deferred | income | at 31 | March 2023 | 4,316,708 | 2,676,360 | 1,099,705 | 887,881 |
| Balance | Balance | |||||
|---|---|---|---|---|---|---|
| 31March | Allocated | 31March | ||||
| 2022 | Income | Expenditure | interest | 2023 | ||
| E | E | E | 6 | E | ||
| nrestricted f | ||||||
| General funds |
7,113,304 | 9,204,883 | (7,957,510) | 188,353 | 8,549,030 | |
| Maternal and Fetal |
Research | |||||
| Unit, Manchester | 94,262 | 189,455 | (177,474) | 3,098 | 109,341 | |
| UKRI Early Career Researcher, Manchester |
243,405 | (113,917) | 129,488 | |||
| Maternal and Fetal |
Research | |||||
| Unit, Edinburgh | ||||||
| Maternal and Fetal |
Research | |||||
| Unit, London | 30,722 | (30,722) | ||||
| National Centre for |
||||||
| Miscarriage Research |
175,238 | 151,391 | (305,120) | 2,451 | 23,960 | |
| UKRI Early Career | ||||||
| Researc he r, Nati on aI Centre for Miscarriage Research |
165,014 | 165,014 | ||||
| National Centre for |
||||||
| Maternity Improvement |
15,003 | 125,000 | (140,000) | 196 | 199 | |
| UKRI Early Career | ||||||
| Researcher, National Centre |
||||||
| for Maternity Improvement |
30,000 | (15,122) | 14,878 | |||
| DCMS Tampon Tax | Fund, | |||||
| National Centre for |
Maternity | |||||
| Improvement | 324,026 | (324,026) | ||||
| Tommy's National |
Centre for | |||||
| Preterm Birth Research |
10,002 | 5,300 | 201 | 15,503 | ||
| Information Services |
46,300 | (46,300) | ||||
| DHSC VCSE Health | and | |||||
| Wellbeing Alliance |
97,000 | (97,000) | ||||
| DHSC VCSE Health | and | |||||
| Wellbeing Alliance |
Priority | |||||
| Project | 12,960 | (12,960) | ||||
| UKRI HappyMums | 3,497 | (3,497) | ||||
| DHSC VCSE Health | and | |||||
| Wellbeing Fund - Pregnancy |
||||||
| and Parenting at Work for SMEs |
145,913 | (145,913) | ||||
| Scottish Executive | 11,994 | (11,994) | ||||
| Total restricted funds |
294,505 | 1,581,977 | (1,424,046) | 5,946 | 458,382 | |
| Total funds | 7,407,809 | 10,786,860 | (9,381,556) | 194,299 | 9,007,412 |
| and treating depression in pregnancy to i outcomes. " |
and treating depression in pregnancy to i outcomes. " |
and treating depression in pregnancy to i outcomes. " |
and treating depression in pregnancy to i outcomes. " |
and treating depression in pregnancy to i outcomes. " |
mprove mot |
hers' and offsp |
ring's m |
ental health |
ental health |
|---|---|---|---|---|---|---|---|---|---|
| Tommy's received one grant from the Scottish |
Government | to develop and |
improve | miscarriage | |||||
| care resources for families | in | Scotland. | |||||||
| Consolidated statement |
of | funds | —previous year | ||||||
| Balance | Balance | ||||||||
| 31March | Allocated | 31March | |||||||
| 2021f | Income | Expendituref | interest | 2022f | |||||
| Unrestricted funds |
|||||||||
| General funds | 6,219,605 | 7,728,618 | (6,837,803) | 2,884 | 7,113,304 | ||||
| Maternal and Fetal Research |
|||||||||
| Unit, Manchester | 87,275 | 108,039 | (101,068) | 16 | 94,262 | ||||
| Maternal and Fetal Research |
|||||||||
| Unit, Edinburgh | 2,000 | (2,000) | |||||||
| Maternal and Fetal Research |
|||||||||
| Unit, London | 281,912 | (281,912) | |||||||
| National Centre for |
|||||||||
| Miscarriage Research |
175,203 | 35 | 175,238 | ||||||
| National Centre for |
|||||||||
| Maternity Improvement |
125,559 | 145,000 | (255,559) | 15,003 | |||||
| DCMS Tampon Tax Fund, | |||||||||
| National Centre for Maternity |
|||||||||
| Improvement | 59,606 | (59,606) | |||||||
| Tommy's National Centre |
for | ||||||||
| Preterm Birth Research |
10,000 | 10,002 | |||||||
| Information Services |
135,296 | 42,499 | (177,795) | ||||||
| DHSC VCSE Health and |
|||||||||
| Wellbeing Alliance |
97,000 | (97,000) | |||||||
| DHSC VCSE Vaccine | |||||||||
| Hesitancy Project |
20,000 | (20,000) | |||||||
| Total restricted funds |
348,130 | 941,259 | (994,940) | 56 | 294,505 | ||||
| Totalfunds | 6,567,735 | 8,669,877 | (7,832,743) | 2,940 | 7,407,809 |
| 20 Charity statement |
offunds | |||||
|---|---|---|---|---|---|---|
| Balance | Balance | |||||
| 31 | March | Allocated | 31March | |||
| 2022 E |
Income E |
Expendituref | interest E |
2023 E |
||
| nr ricted funds |
||||||
| General funds | 7,608,471 | 7,518,258 | (6,753,039) | 175,340 | 8,549,030 | |
| Restricted funds | ||||||
| Maternal and Fetal Research |
||||||
| Unit, Manchester | 94,262 | 189,455 | (177,474) | 3,098 | 109,341 | |
| UKRI Early Career Researcher, Manchester |
243,405 | (113,917) | 129,488 | |||
| Maternal and Fetal Research |
||||||
| Unit, Edinburgh | ||||||
| Maternal and Fetal Research |
||||||
| Unit, London | 30,722 | (30,722) | ||||
| National Centre for |
||||||
| Miscarriage Research |
175,238 | 151,391 | (305,120) | 2,451 | 23,960 | |
| UKRI Early Career | ||||||
| Researcher, National Centre |
||||||
| for Miscarriage Research |
165,014 | 165,014 | ||||
| National Centre for |
||||||
| Maternity Improvement |
15,003 | 125,000 | (140,000) | 196 | 199 | |
| UKRI Early Career | ||||||
| Researcher, National Centre |
||||||
| for Maternity Improvement |
30,000 | (15,122) | 14,878 | |||
| DCMS Tampon Tax Fund, | ||||||
| National Centre for Maternity |
||||||
| Improvement | 324,026 | (324,026) | ||||
| Tommy's National Centre |
||||||
| for Preterm Birth Research |
10,002 | 5,300 | 201 | 15,503 | ||
| Information Services |
46,300 | (46,300) | ||||
| Di-ISC VCSE Health and |
||||||
| Wellbeing Alliance |
97,000 | (97,000) | ||||
| DHSC VCSE Health and |
||||||
| Wellbeing Alliance Priority |
||||||
| Project | 12,960 | (12,960) | ||||
| UKRI HappyMums | 3,497 | (3,497) | ||||
| DHSC VCSE Health and |
||||||
| Wellbeing Fund - Pregnancy |
||||||
| and Parenting at Work for |
||||||
| SMEs | 145,913 | (145,913) | ||||
| Scottish Executive | 11,994 | (11,994) | ||||
| Total restricted funds |
294,505 | 1,581,977 | (1,424,046) | 5,946 | 458,382 | |
| Total funds | 7,902,976 | 9,100,235 | (8,177,085) | 181,286 | 9,007,412 |
| harity statement offunds |
—previous y | ear | |||
|---|---|---|---|---|---|
| Balance | Balance | ||||
| 31March | Allocated | 31March | |||
| 2021 E |
Incomef | Expenditure E |
interest E |
2022 E |
|
| Unrestricted funds |
|||||
| General funds |
7,128,525 | 6,234,278 | (5,757,010) | 2,678 | 7,608,471 |
| Restricted funds | |||||
| Maternal and Fetal |
|||||
| Research Unit, Manchester |
87,275 | 108,039 | (101,068) | 16 | 94,262 |
| Maternal and Fetal |
|||||
| Research Unit, Edinburgh |
2,000 | (2,000) | |||
| Maternal and Fetal |
|||||
| Research Unit, London |
281,912 | (281,912) | |||
| National Centre for |
|||||
| Miscarriage Research |
175,203 | 35 | 175,238 | ||
| National Centre for |
|||||
| Maternity Improvement |
125,559 | 145,000 | (255,559) | 15,003 | |
| DCMS Tampon Tax Fund, | |||||
| National Centre for |
|||||
| Maternity Improvement |
59,606 | (59,606) | |||
| Tommy's National Centre |
|||||
| for Preterm Birth Research |
10,000 | 10,002 | |||
| Information Services |
135,296 | 42,499 | (177,795) | ||
| DHSC VCSE Health and |
|||||
| Wellbeing Alliance |
97,000 | (97,000) | |||
| DHSC VCSE Vaccine | |||||
| Hesitancy Project |
20,000 | (20,000) | |||
| Total restricted funds |
348,130 | 941,259 | (994,940) | 56 | 294,505 |
| Total funds | 7,476,655 | 7,175,537 | (6,751,950) | 2,734 | 7,902I976 |
| ehalf of Tommy's. T re: |
he results of the subsidiary | , which are consolidated on a line |
-by-line basis, |
|---|---|---|---|
| 2023f | 2022 f |
||
| Turnover | 194,795 | 147,014 | |
| Cost of sales | (66,790) | (109,706) | |
| Gross profit | 128,005 | 37,308 | |
| Interest receivable |
309 | 80 | |
| Administration costs |
(82,857) | (58,895) | |
| Profit/(Loss) for the |
year | 45,457 | (21,507) |
| Retained earnings | |||
| At 1 April 2022 | (21,507) | ||
| Results for the year | 45,457 | (21,507) | |
| Distribution to Tommy's |
(23,950) | ||
| At 31 March 2023 | (21,507) | ||
| Balance sheet | |||
| Non-current assets |
12,406 | 23,039 | |
| Current assets | 147,734 | 955,098 | |
| Current liabilities |
(160,138) | (999,642) | |
| Net assets | (21,505) | ||
| Called up share capital Retained earnings |
2 (21,507) |
||
| Equity shareholders' | funds | (21,505) |
| 22 Subsidiary company: |
22 Subsidiary company: |
22 Subsidiary company: |
22 Subsidiary company: |
LLHM Limited | LLHM Limited | LLHM Limited | LLHM Limited | LLHM Limited | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| The statement of financial |
activities | and | the | consolidated | balance | sheet include |
the results, |
|||||||||
| assets and liabilities |
of the | Charity's | wholly | owned | subsidiary, | LLHM Limited |
(a company | |||||||||
| registered in England |
and Wales, | registration | number | 10584979, registered at Nicholas House, 3 |
||||||||||||
| Laurence Pountney Hill, |
London, | EC4R OBB), | which | develops | and | organises fundraising events |
||||||||||
| on behalf of Tommy's. | The | results | of | the | subsidiary, | which | are | consolidated on a line-by-line |
||||||||
| basis, are: | ||||||||||||||||
| 2023 S |
2022f | |||||||||||||||
| Turnover | 2,233,203 | 2,000,226 | ||||||||||||||
| Cost of sales | (971,856) | (915,297) | ||||||||||||||
| Gross profit | 1,261,347 | 1,084,929 | ||||||||||||||
| Interest receivable |
12,704 | 126 | ||||||||||||||
| Administration costs |
(795,506) | (649,798) | ||||||||||||||
| Profit on ordinary activities |
before taxation | 478,545 | 435,257 | |||||||||||||
| Taxation on ordinary |
activities | |||||||||||||||
| Profit for the financial | year | 478,545 | 435,257 | |||||||||||||
| Retained earnings |
||||||||||||||||
| At 1 April 2022 | (473,662) | (908,919) | ||||||||||||||
| Results for the year | 478,545 | 435,257 | ||||||||||||||
| Distribution to Tommy's |
(4,883) | |||||||||||||||
| At 31 March 2023 | (473,662) | |||||||||||||||
| Balance sheet | ||||||||||||||||
| Non-current assets |
12,917 | 4,438 | ||||||||||||||
| Current assets | 3,916,465 | 3,235,318 | ||||||||||||||
| Current liabilities |
(3,929,381) | (3,713,417) | ||||||||||||||
| Net assets/(liabilities) | (473,661) | |||||||||||||||
| Called up share capital Profit and loss account |
1 (473,662) |
|||||||||||||||
| Equity shareholders' | funds | (473,661) |
| 6342,677) in respect of fundraising eve Charity 6704,991(2022: 61,482,918). |
6342,677) in respect of fundraising eve Charity 6704,991(2022: 61,482,918). |
6342,677) in respect of fundraising eve Charity 6704,991(2022: 61,482,918). |
nts. As of 31st Ma |
nts. As of 31st Ma |
rch 2023, LLHM Limit |
ed owed the |
|---|---|---|---|---|---|---|
| 24 Reconciliation of net movement in |
funds to net cash | flow from operating | activities | |||
| 2023 E |
2022f | |||||
| Net movement in funds |
1,599,603 | 840,074 | ||||
| Add back depreciation | and amortisation | charge | 166,928 | 153,716 | ||
| Deduct interest income |
shown | in investing | activities | (194,299) | (2,940) | |
| (Increase) in debtors Increase in creditors |
(1,169,966) 1,615,345 |
(631,714) 651,374 |
||||
| Net cash provided by operating |
activities | 2,017,611 | 1,010,510 |
| 5 Analysis o |
fcash a | nd cash equivalents | ||
|---|---|---|---|---|
| 2023 | 2022 | |||
| 6 | ||||
| Short term deposit | 10,618,710 | 8,604,156 | ||
| Cash at bank and | in hand | 4,166,084 | 4,004,427 | |
| Total cash and cash equivalents | 14,784,794 | 12,608,583 | ||
| 2023 | 2022 | |||
| 6 | 6 | |||
| Cash and cash equivalents | at 1 April 2022 | 12,608,583 | 11,819,695 | |
| Movement | 2,176,211 | 788,888 | ||
| Cash and cash equivalents | at 31 March 2023 | 14,784,794 | 12,608,583 |
| Unrestricted | Restricted | Total | |||
|---|---|---|---|---|---|
| funds | funds | 2023 | |||
| 6 | 6 | ||||
| Fixed | assets | 310,935 | 310,935 | ||
| Cash | at bank and | in hand | 14,326,412 | 458,382 | 14,784,794 |
| Other | net current | liabilities | (6,088,317) | (6,088,317) | |
| Total | 8,549,030 | 458,382 | 9,007,412 |
| Unrestricted | Restricted | Total | |||
|---|---|---|---|---|---|
| funds | funds | 2022 | |||
| 6 | 6 | 6 | |||
| Fixed | assets | 442,164 | 442,164 | ||
| Cash | at bank and | in hand | 12,314,078 | 294,505 | 12,608,583 |
| Other | net current | liabilities | (5,642,938) | (5,642,938) | |
| Total | 7,113,304 | 294,505 | 7,407,809 |
| 7 | Analysis o | f Charity net assets | between funds |
||
|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | |||
| fundsf | fundsf | 2023f | |||
| Fixed | assets | 285,617 | 285,617 | ||
| Cash | at bank and | in hand | 11,460,874 | 458,382 | 11,919,256 |
| Other | net current | liabilities | (3,197,461) | (3,197,461) | |
| Total | 8,549,030 | 458,382 | 9,007,412 |
| Unrestricted | Restricted | Total | |||
|---|---|---|---|---|---|
| funds E |
funds E |
2022f | |||
| Fixed | assets | 414,691 | 414,691 | ||
| Cash | at bank and | in hand | 9,253,602 | 294,505 | 9,548,107 |
| Other | net current | liabilities | (2,059,822) | (2,059,822) | |
| Total | 7,608,471 | 294,505 | 7,902,976 |